Nucleotide excision repair proteins ERCC1 and XPC and tumor-infiltrating lymphocytes are biomarkers of neoadjuvant platinum resistance in high-grade serous ovarian cancer.

被引：0
|
作者：
Scurry, James [1 ]
van Zyl, Belinda [2 ]
Gulliver, Damien [2 ]
Otton, Geoffrey [3 ]
Bowden, Nikola [2 ]
机构：
[1] Pathol NORTH, Newcastle, NSW, Australia
[2] Univ Newcastle, Newcastle, NSW, Australia
[3] Hunter New England Hlth Serv, Newcastle, NSW, Australia
来源：
CLINICAL CANCER RESEARCH | 2018年 / 24卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A43
引用
收藏
页码：61 / 62
页数：2
相关论文
共 48 条
  • [1] Nucleotide Excision Repair Proteins ERCC1 and XPC, and Tumor-Infiltrating Lymphocytes are Biomarkers of Neoadjuvant Platinum Resistance in High-Grade Serous Ovarian Cancer
    Scurry, J.
    van Zyl, B.
    Damien, G.
    Jaaback, K.
    Otton, G.
    Bowden, N.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 7 - 7
  • [2] Nucleotide excision repair protein ERCC1 and tumour-infiltrating lymphocytes are potential biomarkers of neoadjuvant platinum resistance in high grade serous ovarian cancer
    Scurry, James
    van Zyl, Belinda
    Gulliver, Damien
    Otton, Geoffrey
    Jaaback, Kenneth
    Lombard, Janine
    Vilain, Ricardo E.
    Bowden, Nikola A.
    GYNECOLOGIC ONCOLOGY, 2018, 151 (02) : 306 - 310
  • [3] Nomograms to Predict the Density of Tumor-Infiltrating Lymphocytes in Patients With High-Grade Serous Ovarian Cancer
    Dai, Danian
    Liu, Lili
    Huang, He
    Chen, Shangqiu
    Chen, Bo
    Cao, Junya
    Luo, Xiaolin
    Wang, Feng
    Luo, Rongzhen
    Liu, Jihong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [4] Tumor-infiltrating lymphocytes expression in stage IIIc/IV of high-grade serous ovarian cancer: Variation with neoadjuvant chemotherapy and prognostic value
    Barcena, C.
    Rojas, K.
    Lema, L.
    Manso Sanchez, L.
    Rios, J.
    Garcia-Martin, R.
    Maroto, A.
    Rodriguez-Peralto, J. L.
    Ciruelos Gil, E. M.
    Mendiola, D. C.
    Paz-Ares, L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [5] DCLK1 mediates tumor stemness and platinum resistance in high-grade serous epithelial ovarian cancer.
    Moxley, Katherine M.
    Ha, JiHee
    Andrade, Daniel
    Houchen, Courtney
    Dhanasekaran, Danny
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 66 - 67
  • [6] PD-1/PD-L1 EXPRESSION AND TUMOR-INFILTRATING LYMPHOCYTES ARE PROGNOSTICALLY FAVORABLE IN HIGH-GRADE SEROUS OVARIAN CANCER
    de la Fuente, L. Martin
    Fremer, S. Westbom
    Arildsen, N. Skovbjerg
    Hartman, L.
    Malander, S.
    Kannisto, P.
    Masback, A.
    Hedenfalk, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 761 - 761
  • [7] IMMUNE PROPERTIES OF TUMOR-INFILTRATING LYMPHOCYTES IN OVARIAN CLEAR CELL CARCINOMA RELATIVE TO OVARIAN HIGH-GRADE SEROUS CARCINOMA
    Park, Junsik
    Kim, Jung Chul
    Lee, Mi-Ran
    Lee, Joohyang
    Kim, Sunghoon
    Kim, Sang Wun
    Lee, Jung-Yun
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A28 - A29
  • [8] The Role of the Extracellular Matrix and Tumor-Infiltrating Immune Cells in the Prognostication of High-Grade Serous Ovarian Cancer
    Belotti, Yuri
    Lim, Elaine Hsuen
    Lim, Chwee Teck
    CANCERS, 2022, 14 (02)
  • [9] The tumor immune microenvironment correlates with neoadjuvant chemotherapy response in high-grade serous ovarian cancer.
    Zhu, Lei
    Cao, Guangming
    Hua, Dingchao
    Cui, Lina
    Zhao, Xiaochen
    Wang, Shuzhen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17605 - E17605
  • [10] Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
    Goode, Ellen L.
    Block, Matthew S.
    Kalli, Kimberly R.
    Vierkant, Robert A.
    Chen, Wenqian
    Fogarty, Zachary C.
    Gentry-Maharaj, Aleksandra
    Toloczko, Aleksandra
    Hein, Alexander
    Bouligny, Aliecia L.
    Jensen, Allan
    Osorio, Ana
    Hartkopf, Andreas D.
    Ryan, Andy
    Chudecka-Glaz, Anita
    Magliocco, Anthony M.
    Hartmann, Arndt
    Jung, Audrey Y.
    Gao, Bo
    Hernandez, Brenda Y.
    Fridley, Brooke L.
    McCauley, Bryan M.
    Kennedy, Catherine J.
    Wang, Chen
    Karpinskyj, Chloe
    de Sousa, Christiani B.
    Tiezzi, Daniel G.
    Wachter, David L.
    Herpel, Esther
    Taran, Florin Andrei
    Modugno, Francesmary
    Nelson, Gregg
    Lubinski, Jan
    Menkiszak, Janusz
    Alsop, Jennifer
    Lester, Jenny
    Garcia-Donas, Jesus
    Nation, Jill
    Hung, Jillian
    Palacios, Jose
    Rothstein, Joseph H.
    Kelley, Joseph L.
    de Andrade, Jurandyr M.
    Robles-Diaz, Luis
    Intermaggio, Maria P.
    Widschwendter, Martin
    Beckmann, Matthias W.
    Ruebner, Matthias
    Jimenez-Linan, Mercedes
    Singh, Naveena
    JAMA ONCOLOGY, 2017, 3 (12)
12345